-
MOQ
5 Box
- Country of OriginIndia
-
Supply Type
Exporter, Supplier, Retailer, Distributor
-
Preferred Buyer Location
All over the world
Hepcinat-Plus is used as a treatment for chronic hepatitis C virus (HCV) infection. It is a generic fixed-dose combination drug, which consists of Sofosbuvir 400 mg and Daclatasvir 60 mg. Natco Pharma is India’s first company to launch combination of Sofosbuvir+Daclatasvir in one tablet under its brand name Hepcinat-Plus.